A Revolution in Breast Cancer Prevention Is Underway—With AI Mammogram-Based Risk Assessment Starting at 35

Genentech’s Giredestrant Combination Significantly Improved Progression-Free Survival in ER-positive Advanced Breast Cancer in Phase III evERA Data Published in The New England Journal of Medicine

2026 National Black Breast Cancer Summit Returns to Houston

Aggressive Breast Cancer Has a New Weakness, Study Finds – Newsweek